Correlation Between LianBio ADR and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both LianBio ADR and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LianBio ADR and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between LianBio ADR and Edgewise Therapeutics, you can compare the effects of market volatilities on LianBio ADR and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LianBio ADR with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of LianBio ADR and Edgewise Therapeutics.
Diversification Opportunities for LianBio ADR and Edgewise Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between LianBio and Edgewise is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding LianBio ADR and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and LianBio ADR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LianBio ADR are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of LianBio ADR i.e., LianBio ADR and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between LianBio ADR and Edgewise Therapeutics
If you would invest 599.00 in Edgewise Therapeutics on August 24, 2024 and sell it today you would earn a total of 2,638 from holding Edgewise Therapeutics or generate 440.4% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 0.4% |
| Values | Daily Returns |
LianBio ADR vs. Edgewise Therapeutics
Performance |
| Timeline |
| LianBio ADR |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Edgewise Therapeutics |
LianBio ADR and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with LianBio ADR and Edgewise Therapeutics
The main advantage of trading using opposite LianBio ADR and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LianBio ADR position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.| LianBio ADR vs. Sensei Biotherapeutics | LianBio ADR vs. NextCure | LianBio ADR vs. Nuvation Bio | LianBio ADR vs. Inozyme Pharma |
| Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Hookipa Pharma | Edgewise Therapeutics vs. Cingulate Warrants | Edgewise Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |